InDex Pharmaceuticals Holding AB (FLERIE) Stock Statistics & Valuation Metrics

InDex Pharmaceuticals Holding AB has a market cap or net worth of €2.91B. The enterprise value is kr2.78B.

InDex Pharmaceuticals Holding AB has 77,455,960 shares outstanding. The number of shares has decreased by -2.65% in one year.

InDex Pharmaceuticals Holding AB’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -2.64%.

The current PE Ratio of InDex Pharmaceuticals Holding AB is ―. InDex Pharmaceuticals Holding AB’s PEG ratio is 0.18.

In the last 12 months, InDex Pharmaceuticals Holding AB had revenue of 100.00K and earned -228.00M in profits. Earnings per share was -3.24.

In the last 12 months, operating cash flow was -17.50M and capital expenditures 0.00, giving a free cash flow of -17.50M billion.

InDex Pharmaceuticals Holding AB pays an annual dividend of ―, resulting in a dividend yield of ―

InDex Pharmaceuticals Holding AB upcoming earnings date is Jan 21, 2026, TBA (Confirmed).

InDex Pharmaceuticals Holding AB as a current ratio of 55.39, with Debt / Equity ratio of 0.01%

In the past 12 months, InDex Pharmaceuticals Holding AB has paid 100.00K in taxes.

InDex Pharmaceuticals Holding AB EV to EBITDA ratio is -10.82, with an EV/FCF ratio of -143.78.

InDex Pharmaceuticals Holding AB has €510.70M in cash and marketable securities with €500.00K in debt, giving a net cash position of €510.20M billion.

Gross margin is -102.86%, with operating margin of -110800.00%, and net profit margin of -228000.00%.

The average price target for InDex Pharmaceuticals Holding AB is ―, which is 11.43% higher than the current price. The consensus rating is ―